Historical record - last NADAC effective date: 9/19/2018
Product Information
SENSIPAR 90 MG TABLET is a brand product labeled by Amgen Inc., priced at $78.2590 per EA under NDC 55513007530. Its NADAC has been published 303 times since Nov 28, 2013.
FDA first approved this application on Mar 8, 2004.
Strength
90 mg/1
Manufacturer
Amgen Inc.NDC
55513007530
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/19/2018
Active Ingredients
CINACALCET HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021688FDA Approved
3/8/2004
On Market Since
4/4/2004
Pharmacological Classes
Price Statistics
The NADAC for SENSIPAR 90 MG TABLET has been published 303 times since Nov 28, 2013, and over the history we have for it it has risen 73.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $78.2590 per EA |
|---|---|
| All-time high | $78.8812 (Feb 15, 2017) |
| All-time low | $45.0746 (Nov 28, 2013) |
| Median price | $73.0435 |
| Average price | $67.4468 |
| Largest weekly change | +8.0% (Jul 27, 2016) |
| Weeks tracked | 303 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+73.6%
Last surveyed Sep 11, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the cinacalcet hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cinacalcet hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium-sensing Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SENSIPAR 90 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SENSIPAR 90 MG TABLET, manufactured by Amgen Inc., is $78.2590 per EA (NDC 55513007530), effective Sep 11, 2019.
How has the price of SENSIPAR 90 MG TABLET changed over time?
Over the history we have for it, the NADAC for SENSIPAR 90 MG TABLET has risen 73.6%. It has been tracked across 303 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SENSIPAR 90 MG TABLET?
Since Nov 28, 2013, the NADAC for SENSIPAR 90 MG TABLET has ranged from a low of $45.0746 (Nov 28, 2013) to a high of $78.8812 (Feb 15, 2017), with a median of $73.0435 per EA.
Are there cheaper alternatives to SENSIPAR 90 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SENSIPAR 90 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SENSIPAR 90 MG TABLET?
SENSIPAR 90 MG TABLET (NDC 55513007530) is labeled by Amgen Inc., and CMS classifies it as a brand product.